Clinical and functional characterisation of a recurrent KCNQ1 variant in the Belgian population ...

Abstract Background The c.1124_1127delTTCA p.(Ile375Argfs*43) pathogenic variant is the most frequently identified molecular defect in the KCNQ1 gene in the cardiogenetics clinic of the Antwerp University Hospital. This variant was observed in nine families presenting with either Jervell-Lange-Nielsen syndrome or long QT syndrome (LQTS). Here, we report on the molecular, clinical and functional characterization of the KCNQ1 c.1124_1127delTTCA variant. Results Forty-one heterozygous variant harboring individuals demonstrated a predominantly mild clinical and electrophysiological phenotype, comp... Mehr ...

Verfasser: Sieliwonczyk, Ewa
Alaerts, Maaike
Simons, Eline
Snyders, Dirk
Nijak, Aleksandra
Vandendriessche, Bert
Schepers, Dorien
Akdeniz, Dogan
Van Craenenbroeck, Emeline
Knaepen, Katleen
Rabaut, Laura
Heidbuchel, Hein
Van Laer, Lut
Saenen, Johan
Labro, Alain J.
Loeys, Bart
Dokumenttyp: Datenquelle
Erscheinungsdatum: 2023
Verlag/Hrsg.: figshare
Schlagwörter: Medicine / Genetics / FOS: Biological sciences / Evolutionary Biology / 69999 Biological Sciences not elsewhere classified / Cancer / 111714 Mental Health / FOS: Health sciences / 60506 Virology
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-28885417
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dx.doi.org/10.6084/m9.figshare.c.6584846

Abstract Background The c.1124_1127delTTCA p.(Ile375Argfs*43) pathogenic variant is the most frequently identified molecular defect in the KCNQ1 gene in the cardiogenetics clinic of the Antwerp University Hospital. This variant was observed in nine families presenting with either Jervell-Lange-Nielsen syndrome or long QT syndrome (LQTS). Here, we report on the molecular, clinical and functional characterization of the KCNQ1 c.1124_1127delTTCA variant. Results Forty-one heterozygous variant harboring individuals demonstrated a predominantly mild clinical and electrophysiological phenotype, compared to individuals harboring other KCNQ1 pathogenic variants (5% symptomatic before 40 years of age, compared to 24% and 29% in p.(Tyr111Cys) and p.(Ala341Val) variant carriers, respectively, 33% with QTc ≤ 440 ms compared to 10% in p.(Tyr111Cys) and p.(Ala341Val) variant carriers). The LQTS phenotype was most comparable to that observed for the Swedish p.(Arg518*) founder mutation (7% symptomatic at any age, compared ...